Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Tenax Therapeutics Inc (TENX)  
$0.26 0.00 (0.00%) as of 4:30 Tue 1/2


Download
   
Exchange: OTC Bulletin Board
Security Type: Common
Shares Out: 44,696,000
Market Cap: 11.62(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.156 - $0.62
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Tenax Therapeutics is focused on identifying, developing and commercializing late-stage pharmaceutical therapeutic products for serious cardiovascular and pulmonary diseases. Co. owns a license granting Life Newco, Inc., its wholly owned subsidiary, a sublicensable right to develop and commercialize pharmaceutical products containing levosimendan. Co.'s programs include: TNX-103 and TNX-102 (levosimendan), a calcium sensitizer/K-ATP activator developed for intravenous use in hospitalized patients with acutely decompensated heart failure; and TNX-201(imatinib), a tyrosine kinase inhibitor, which changed the treatment of chronic myeloid leukemia.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-03-03 2023-12-01 2023-06-02 2022-06-02

   
Records found: 172
  Page 5 of 7  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Jebsen Michael B Chief Financial Officer   •       –      –    2013-02-15 4 $0.68 $220 D/D 324 25,859     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2013-01-15 4 $0.64 $207 D/D 324 26,183     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-12-01 4 $0.69 $193 D/D 279 26,507     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-11-01 4 $1.05 $293 D/D 279 26,786     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-10-01 4 D $0.60 $167 D/D (279) 27,065     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-09-15 4 D $0.88 $246 D/D (279) 27,344     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-08-31 4 A $1.84 $27,486 D/D 14,938 27,623     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-08-15 4 D $1.07 $299 D/D (279) 12,685     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-07-01 4 D $1.57 $438 D/D (279) 12,964     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-06-01 4 D $2.01 $561 D/D (279) 13,243     -
   Blanck Ronald R Director   –       •      –    2012-05-01 4 A $1.78 $33,751 D/D 18,961 43,479     -
   Chatfield William A. Director   –       •      –    2012-05-01 4 A $1.78 $33,751 D/D 18,961 42,289     -
   Rallis Chris A Director   –       •      –    2012-05-01 4 A $1.78 $33,250 D/D 18,680 25,773     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-04-15 4 D $2.35 $721 D/D (307) 5,201     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-03-15 4 D $2.69 $831 D/D (309) 5,508     -
   Jebsen Michael B President and CFO   •       –      –    2012-02-15 4 D $2.00 $618 D/D (309) 5,817     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2012-01-15 4 D $1.43 $442 D/D (309) 6,126     -
   Rallis Chris A Director   –       •      –    2011-12-16 3 IO $0.00 $0 D/D 0 7,073     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2011-12-15 4 D $1.91 $533 D/D (279) 6,435     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2011-11-15 4 D $2.11 $589 D/D (279) 6,714     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2011-10-14 4 D $2.09 $583 D/D (279) 6,993     -
   Klein Gerald L Chief Medical Officer   •       –      –    2011-10-14 4 D $2.09 $508 D/D (243) 13,542     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2011-09-12 4 D $2.28 $636 D/D (279) 7,272     -
   Klein Gerald L Chief Medical Officer   •       –      –    2011-09-12 4 D $2.28 $554 D/D (243) 13,785     -
   Jebsen Michael B Chief Financial Officer   •       –      –    2011-08-10 4 D $2.47 $689 D/D (279) 7,551     -
  172 Records found
  1  2  3  4  5  6  7   
  Page 5 of 7
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us